US 11166985
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted A61KA61K2239/48A61K38/00
Quick answer
US patent 11166985 (Materials and methods for engineering cells and uses thereof in immuno-oncology) held by CRISPR THERAPEUTICS AG expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2239/48, A61K38/00, A61K40/11, A61K40/31